Categories
Archives
- 2026
- 2025
- 2024
- 2023
Nov
16
Investing in Brighter Futures: UCB and the UCB Family Epilepsy Scholarship Program™
Nov
11
UCB Announces 11 Inaugural Recipients of Annual Hidradenitis Suppurativa Scholarship™
Nov
06
BE BOLD: BIMZELX® (bimekizumab-bkzx) builds on superior joint responses versus SKYRIZI® (risankizumab-rzaa) at Week 16, with clinical improvements sustained through Week 24
Nov
04
UCB opens applications for 2027 UCB Myasthenia Gravis Scholarship™
Oct
23
UCB Establishes the Emmanuel Janssen Endowed Chair for the Evaluation of Medicines at Brigham and Women's Hospital
Oct
16
UCB announces U.S. FDA approval for ZILBRYSQ® (zilucoplan) autoinjector self-administration for adults living with generalized myasthenia gravis
Oct
12
UCB Launches Wear It Out, a Community-Driven Program Created For and With People Living With Hidradenitis Suppurativa, Plaque Psoriasis, and Psoriatic Arthritis
Oct
09
UCB Dedicates Site for New U.S. Biologics Manufacturing Campus in Georgia
Sep
30
Inside a PowerHouSe: Conversations, Connection & Learning at the 2026 UCB HS Summit